Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

Typo: DR-70 was cleared by the FDA in 2008, not 2006. This date is important because prior to FDA clearance, the AMDL "longs" used this argument to explain why global sales of DR-70 were so dismal prior to 2008: "the world won't start using DR-70 until it's cleared in the USA. As soon as the FDA clears DR-70, sales will skyrocket."

For anyone interested in doing real DD about this company, start here, in 1996:

http://www.thefreelibrary.com/AMDL+ANNOUNCES+EXCLUSIVE+DISTRIBUTION+AGREEMENT+FOR+DR-70%28TM%29+CANCER...-a018021957

Pay particular attention to this statement:

"Under the terms of the exclusive agreement, Brilliant International must make minimum revenue payments totaling US$5.3 million for the DR-70(TM) test kits on an established escalating annual schedule over the next five years."

This type of hype PR was repeated several times in the ensuing 15 years for various countries, always promising multi-million $$$ revenues, ending with the Guar Diagno distribution agreement of 2011.

None of the revenue predictions ever came close to being true.

Anyone doing serious DD on this company should read those PR's. And, pay special attention to what happened in Great Britain in 2000-2001.